GSK Consumer Healthcare announces new Asia Pacific Regional Head
January 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline
GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
Hikma bring in new CSO
January 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hikma, biotech, drugs, pharma, pharmaceutical
Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …
Boehringer’s Gilotrif approved in US for lung cancer with non-resistant EGFRs
January 16, 2018Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Cancer, FDA, Giltrif, NSCLC, lung cancer
Boehringer Ingelheim is celebrating the FDA’s decision to expand the indication of its lung cancer drug Gilotrif (afatinib) to include …
Mundipharma signs Chinese licensing and distribution agreement with Grünenthal
January 16, 2018Manufacturing and Production China, Grunenthal, Mundipharma, Tramal, pharma
US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on …
Novartis debuts new data showing Cosentyx’s superiority over Janssen’s Stelara in psoriasis
January 16, 2018Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma
Novartis has lifted the curtain on new data comparing the efficacy of Cosentyx (secukinumab) to Janssen’s Stelara (ustekinumab) in achieving …
FDA expands indication of Teva’s Trisenox for acute promyelocytic leukaemia
January 16, 2018Manufacturing and Production, Sales and Marketing FDA, Teva, acute promyelocytic leukaemia, leukaemia, pharma
Teva has announced that its Trisenox (arsenic trioxide) injection has been awarded US approval from the FDA in combination with …
Asthma carves $82 billion out of US economy every year
January 15, 2018Manufacturing and Production, Medical Communications asthma, biotech, drugs, pharma, pharmaceutical
A study created by researchers at the Centers for Disease Control and Prevention has estimated that asthma is costing the …
Seizing opportunities in the next steps for real world evidence
January 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may …
Teva settles with Israeli authorities over international bribery
January 15, 2018Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Just over a year ago, Teva closed a case with US authorities by agreeing to pay a $519 million fine …
Shire scores European approval for Adynovi in haemophilia A
January 15, 2018Sales and Marketing Adynovi, Europe, European Commission, Shire, haemophilia, haemophilia a, pharma
Shire has revealed that the European Commission has approved Adynovi (antihaemophilic factor (recombinant), PEGylated) for on-demand and prophylactic use in …
Sanofi agrees to reimburse Philippines’ Dengvaxia stockpiles
January 15, 2018Sales and Marketing Philippines, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi has agreed with the Department of Health (DoH) for the Philippines to reimburse $27.86 million worth of vaccines, though …
AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer
January 15, 2018Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma
The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …
Universal flu vaccine receives Google’s financial backing
January 15, 2018Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical
Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …
Top Ten most popular articles on Pharmafile.com this week
January 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, HIV, J&J, JJ, Johnson & Johnson, Pfizer, Shire, Teva, Xarelto, patient reported outcomes
The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …
FDA steps in to prohibit codeine cough syrups for children
January 12, 2018Medical Communications FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced that it will require all labels to state that cough syrups containing codeine or hydrocodone are …
Roche’s Ocrevus gets the go ahead in Europe for two forms of MS
January 12, 2018Medical Communications, Sales and Marketing Europe, European Commission, Ocrevus, Roche, multiple sclerosis, pharma
Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the …
BRCA gene mutation found not to impact survival
January 12, 2018Medical Communications, Research and Development
The BRCA1 and BRCA2 genes are known to significantly increase the chances of a woman developing cancer and it was …
Another Alzheimer’s drug bites the dust in P3
January 12, 2018Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and
Novartis prises Pfizer’s Oncology Head away
January 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical
Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …
Teva execs feel the pinch, after pay halved
January 11, 2018Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
